Allon appoints new chief medical officer
This article was originally published in Scrip
Executive Summary
Dr Michael Gold has been named vice-president of clinical development and chief medical officer at Allon Therapeutics. He joins from GlaxoSmithKline, where he most recently served as vice-president of neuroscience medicines.